Alvotech (ALVO) vs Phibro Animal Health Corporation (PAHC)
- Alvotech ALVO 5.00 −5.84%
- Phibro Animal Health Corporation PAHC 38.82 +2.21%
Alvotech and Phibro Animal Health Corporation are both Drug Manufacturers Specialty & Generic companies. Alvotech is the larger, with a market value of $2.1B against $1.5B — 1.3× the size. Alvotech has negative trailing earnings, so its P/E is not meaningful; Phibro Animal Health Corporation trades at 15.8×. Alvotech grew revenue faster over the last twelve months: 364.3% against 17.1%. Phibro Animal Health Corporation has the higher net margin (6.57% vs −101.1%) and the higher return on invested capital (11.7% vs 0.00%). Across the 17 metrics below, Phibro Animal Health Corporation leads on 13 and Alvotech on 4.
Valuation
Profitability
| Metric | ALVO | PAHC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 33.76% | 53.94% |
| Operating margin | (42.43%) | 12.81% | 0.00% |
| Net margin | (101.05%) | 6.57% | 0.00% |
| Free cash flow margin | 0.00% | 0.65% | 0.00% |
| Return on equity | 0.00% | 29.72% | (0.40%) |
| Return on assets | 0.00% | 6.97% | (3.32%) |
| Return on invested capital | 0.00% | 11.72% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack